Journal of Southern Medical University ›› 2006, Vol. 26 ›› Issue (12): 1715-1719.

Previous Articles     Next Articles

Construction of a retroviral vector for RNA interference targeting human telomerase reverse transcriptase

WANG Quan-shi1,WANG Xin-lu2,LI Hua3,WANG Qiao-yu1,WANG Quan-ying4,YANG Guang-xiao4 1PET Center,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China;2PET Center of Department of Nuclear Medicine,Guangzhou General Hospital of Guangzhou Command,Guangzhou 510010,China;3Third Affiliated Hospital of Sun Yat-sen University,Guangzhou 510630,China;4Xi’an Huaguang Bioengineering Company,Xi’an 710025,China   

  1. 南方医科大学南方医院PET中心; 广州军区广州总医院核医学科PET中心; 中山大学附属第三医院; 西安华广生物工程公司; 西安华广生物工程公司 广东广州510515; 广东广州510010; 广东广州510630; 广东广州510515; 陕西西安710025;
  • Online:2006-12-20 Published:2006-12-20

Abstract: Objective To construct a recombinant retroviral vector for RNA interference targeting human telomerase reverse transcriptase(hTERT).Methods The sequences coding for enhanced fluorescence protein(EGFP),U6 promoter and a small interfering RNA(siRNA)targeting hTERT were amplified by PCR,respectively,and sub-cloned sequentially into the retroviral shuttle plasmid pLXSN to construct the plasmid pLXSN-EGFP-U6-siTERT.The recombinant expression plasmid was identified by restriction enzyme digestion and sequencing.Fluorescence microscopy and flow cytometry were employed to analyze EGFP expression in NIH3T3 transfected with the recombinant plasmid,and MMT assay was performed to evaluate the growth inhibition of Hela cells resulting from RNA interference mediated by the plasmid.Results Sequence analysis and restriction enzyme digestion showed that the recombinant expression plasmid pLXSN-EGFP-U6-siTERT was constructed successfully.Twenty-four hours after transfection of NIH3T3 cells with the recombinant plasmid,the expression rate of EGFP reached 24.1% as shown by flow cytometry.MTT assay demonstrated a cell death rate of 53.2% 72 h after transfection of Hela cells with the plasmid.Conclusion The successful construction of the recombinant retroviral plasmid mediating potent cell growth inhibition suggests the great potential of RNA interference technique in suppressing hTERT expression in mammalian tumor cells.

CLC Number: